ClinicalTrials.Veeva
Menu

Find clinical trials for Asthma in Taipei City

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Pulmonary Eosinophilia
Allergic Rhinitis
Rhinitis
Chronic Obstructive Pulmonary Disease
Dust Mite Allergy
Lung Diseases
Disease

Asthma trials near Taipei City, TWN:

A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)

in patients ≥ 6 to \< 18 years of age with severe eosinophilic asthma, including a well-documented history of asthma exacerbations ...

Enrolling
Asthma
Drug: Placebo
Drug: Benralizumab

Phase 3

AstraZeneca
AstraZeneca

Taipei, Taiwan and 116 other locations

The purpose of this study is to evaluate dexpramipexole as an add-on oral therapy in participants with inadequately controlled eosinophilic asthma...

Active, not recruiting
Asthma Attack
Asthma; Eosinophilic
Drug: Dexpramipexole Dihydrochloride
Drug: Placebo

Phase 3

Areteia Therapeutics

Taipei, Taiwan and 335 other locations

Asthma is a chronic condition marked by narrowed and swollen airways due to inflammation leading to recurring symptoms that can vary and wor...

Enrolling
Asthma
Biological: Depemokimab

Phase 3

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Taipei, Taiwan and 49 other locations

placebo-controlled and double-blind study to evaluate the efficacy and safety of FB825 in adult patients with moderate-to-severe allergic asthma...

Enrolling
Allergic Asthma
Drug: Placebo
Drug: FB825

Phase 2

Oneness Biotech

Taipei, Taiwan and 12 other locations

PF-07275315) for the potential treatment of moderate-to-severe asthma. Asthma is a condition that makes it challenging to breathe, ...

Enrolling
Asthma
Other: Placebo
Drug: PF-07275315

Phase 2

Pfizer
Pfizer

Taipei, Taiwan and 131 other locations

trifenatate (FF/UMEC/VI) with inhaled corticosteroids/long-acting beta-2 agonists (ICS/LABA) in adult participants with uncontrolled asthma...

Active, not recruiting
Asthma
Drug: Fluticasone furoate/umeclidinium bromide/vilanterol trifenatate
Drug: Inhaled corticosteroids/long-acting beta-2 agonists

Phase 4

GlaxoSmithKline (GSK)
GlaxoSmithKline (GSK)

Taipei, Taiwan and 116 other locations

per actuation manufactured by two different manufacturers using methacholine bronchoprovocation challenge test in patients with stable mild asthma...

Enrolling
Mild Asthma
Other: Methacholine
Other: Albuterol Sulfate inhalation Placebo
Intech Biopharm

Taipei City, Taiwan and 11 other locations

This is a parallel-group, Phase 2, randomized, double-blind, placebo-controlled, 2-arm study for the treatment of asthma.The purpose of this...

Active, not recruiting
Asthma
Drug: Budesonide/Albuterol
Drug: Lunsekimig

Phase 2

Sanofi
Sanofi

Taipei, Taiwan and 238 other locations

phase IIb study designed to assess efficacy and safety of tozorakimab administered subcutaneously in adult participants with uncontrolled asthma...

Enrolling
Asthma
Drug: Placebo
Drug: Tozorakimab

Phase 2

AstraZeneca
AstraZeneca

Taipei, Taiwan and 212 other locations

decline in adult patients with uncontrolled moderate to severe asthma.The estimated duration is 4±1 weeks of screening and run-in period, fo...

Active, not recruiting
Asthma
Drug: Placebo
Drug: Dupilumab

Phase 4

Sanofi
Sanofi

Taipei, Taiwan and 260 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems